Targeting Neuroinflammation and Peripheral Nerve Dysfunction in Refractory Postherpetic Neuralgia: A Multimodal Injection Case Series
American Journal of Case Reports · 27.05.2026 · 27
DOI: 10.12659/ajcr.951991 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Case Reports, online erschienen am 27.05.2026. Verfasst von Grady Janitra und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia. Hauptthemen laut MEDLINE: Neuralgia, Postherpetic, Neuroinflammatory Diseases. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia.
- Department of Anesthesiology and Intensive Care, Dr. Soetomo General Academic Hospital, Surabaya, East Java, Indonesia.
- Department of Anesthesiology and Pain Management, Maastricht University Medical Center, Maastricht, Netherlands.
ORCID-Profile: Dedi Susila, Liong Liem
Zitieren
APA
Janitra, G., Susila, D., & Liem, L. (2026). Targeting Neuroinflammation and Peripheral Nerve Dysfunction in Refractory Postherpetic Neuralgia: A Multimodal Injection Case Series. American Journal of Case Reports, 27. https://doi.org/10.12659/ajcr.951991
Vancouver
Janitra G, Susila D, Liem L. Targeting Neuroinflammation and Peripheral Nerve Dysfunction in Refractory Postherpetic Neuralgia: A Multimodal Injection Case Series. American Journal of Case Reports. 2026;27. doi:10.12659/ajcr.951991
BibTeX
@article{Janitra2026,
author = {Janitra, Grady and Susila, Dedi and Liem, Liong},
title = {Targeting Neuroinflammation and Peripheral Nerve Dysfunction in Refractory Postherpetic Neuralgia: A Multimodal Injection Case Series},
journal = {American Journal of Case Reports},
year = {2026},
volume = {27},
doi = {10.12659/ajcr.951991}
}
EUVIMED